Join
Live feed
·
PRReleasevia Quantisnow
DiaMedica Therapeutics Inc. logo

DiaMedica Therapeutics Announces Expansion of DM199 (Rinvecalinase Alfa) Program Into Preeclampsia

ByQuantisnow·Wall Street's wire, on your screen.
DMAC· DiaMedica Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DMAC (DiaMedica Therapeutics Inc.) and more on Quantisnow.